VNDA has been in the news 462% more than usual
Jan 08, 2026, 1:33 PM
-15.56%
What does VNDA do
Vanda Pharmaceuticals, headquartered in Washington, D.C., develops therapies for unmet medical needs and has three commercial products, including HETLIOZ and Fanapt. The company also has multiple drugs in development.
VNDA has been in the news recently: In December, Vanda Pharmaceuticals Inc. received FDA approval for Nereus (tradipitant) to prevent motion-induced vomiting. However, the FDA did not approve Vanda’s supplemental New Drug Application for HETLIOZ® to treat jet lag, despite positive clinical trial results.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.